doi: 10.1038/ng.2996
GLP-1 Users Had Higher Alopecia Rates After those adjustments, GLP-1 receptor agonist use was associated with a 37% higher risk of alopecia compared with SGLT-2 inhibitor use (6.91 v 5.04 per 1,000 person years)
More serious but rare adverse events include pancreatitis, gallbladder events, and hypoglycemia (primarily in patients using insulin simultaneously)
The reality is that shifts in estrogen, progesterone, and cortisol can show up in your 30s, 40s, and beyond, often in ways that are easy to dismiss at first until they start affecting your day-to-day life
A very high dose of 30 g shows little difference between males and females
Research suggests that more than half of people using the drugs stop taking them after six months, most often because they cant afford them